Cargando…
Platelet-Derived Growth Factor Is Associated with Progression of Symptomatic Intracranial Atherosclerotic Stenosis
BACKGROUND AND PURPOSE: We aimed to determine the relationships of 33 biomarkers of inflammation, oxidation, and adipokines with the risk of progression of symptomatic intracranial atherosclerotic stenosis (ICAS). METHODS: Fifty-two of 409 patients who participated in the TOSS-2 (Trial of Cilostazol...
Autores principales: | Kim, Kyeong Joon, Jeong, Sang Wuk, Ryu, Wi-Sun, Kim, Dong-Eog, Saver, Jeffrey L., Kim, Jong S., Kwon, Sun U. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Neurological Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7840326/ https://www.ncbi.nlm.nih.gov/pubmed/33480201 http://dx.doi.org/10.3988/jcn.2021.17.1.70 |
Ejemplares similares
-
Association of Systolic Blood Pressure with Progression of Symptomatic Intracranial Atherosclerotic Stenosis
por: Park, Jong-Ho, et al.
Publicado: (2017) -
Outcome of Endovascular Treatment in Symptomatic Intracranial Vascular Stenosis
por: Suh, Dae Chul, et al.
Publicado: (2005) -
Total small vessel disease burden and functional outcome in patients with ischemic stroke
por: Ryu, Wi-Sun, et al.
Publicado: (2020) -
Is the future of symptomatic intracranial atherosclerotic stenosis management promising?
por: Liu, Dacheng, et al.
Publicado: (2020) -
Enterprise stent for symptomatic complex intracranial atherosclerotic stenosis: safety and efficiency
por: Dong, Yanhua, et al.
Publicado: (2019)